Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in endometrial cancer

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2837-2843

  Salehin, Darius ^a   Fromberg, Iris ^c   Haugk, Christina ^a   Dohmen, Birgit ^b   Georg, Thomas ^c   Bohle, Rainer Maria ^c   Bauerschlag, Dirk ^d   Maass, Nicolai ^d   Friedrich, Michael ^a  

^a Helios Hospital Krefeld   (Germany)

^b Institute of Pathology   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Calpain; Calpastatin; Endometrial cancer

Indexed keywords

CALPAIN 1; CALPAIN 2; CALPASTATIN; PARAFFIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; COMPARATIVE STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TUMOR VOLUME;

CALCIUM-BINDING PROTEINS; CALPAIN; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING;

EID: 77955811866     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kurzeder C, Sauer G and Kreienberg R: Epidemiology of endometrial cancer. Gynäkologe 40: 10-13, 2007.
2. Medverd JR and Dubinsky TJ: Cost analysis model: US versus endometrial biopsy in evaluation of peri- and postmenopausal abnormal vaginal bleeding. Radiology 222: 619-627, 2002.
3. Dubinsky TJ, Parvey HR and Maklad N: The role of transvaginal sonography and endometrial biopsy in the evaluation of peri- and postmenopausal bleeding. AJR Am J Roentgenol 169: 145-149, 1997.
4. Mendivil A, Schuler KM and Gehrig PA: Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. Cancer Control 16: 46-52, 2009.
5. Marchetti M, Vasile C and Chiarelli S: Endometrial cancer: asymptomatic endometrial findings characteristics of postmenopause endometrial cancer. Eur J Gynecol Oncol 26: 479-484, 2005. (Pubitemid 41585927)
6. Creasman WT: Prognostic significance of hormone receptors. Cancer 71: 1467-1470, 1993.
7. 2+-sensitive thiol protease (calpain I) and its specific inhibitor protein (calpastatin). J Biochem 90: 1809-1816, 1981.
8. Tullio RD, Passalacqua M, Averna M, Salamino F, Melloni E and Pontremoli S: Changes in intracellular localization of calpastatin during calpain activation. Biochem J 343: 467-472, 1999. (Pubitemid 29511783)
9. Crawford C, Brown NR and Willis AC: Studies of the active site of m-calpain and the interaction with calpastatin. Biochem J 296: 135-142, 1993. (Pubitemid 23344740)
10. Mellgren RL: Canine cardiac calcium-dependent proteases: Resolution of two forms with different requirements for calcium. FEBS Lett 109: 129-133, 1980.
11. Pietsch M, Chua KC and Abell AD: Calpains: attractive targets for the development of synthetic inhibitors. Curr Top Med M 10: 270-293, 2010.
12. Carragher NO: Calpain inhibition: a therapeutic strategy targeting multiple disease states. Curr Pharm Des 12: 615-638, 2006.
13. Melloni E, Michetti M, Salamino F, Minafra R and Pontremoli S: Modulation of the calpain autoproteolysis by calpastatin and phospholipids. Biochem Biophys Res Commun 229: 193-197, 1996. (Pubitemid 27013730)
14. Carafoli E and Molinari M: Calpain: a protease in search of a function? Biochem Biophys Res Commun 247: 193-203, 1998.
15. Ono Y, Sorimachi H and Suzuki K: Structure and physiology of calpain, an enigmatic protease. Biochem Biophys Res Commun 245: 289-294, 1998. (Pubitemid 28418493)
16. Wang KK: Calpain and caspase: can you tell the difference? Trends Neurosci 23: 20-26, 2000.
17. Zatz M and Starling A: Calpains and disease. N Engl J Med 352: 2413-2423, 2005.
18. Arora AS, de Green PC, Croall DE, Emori Y and Gores GJ: Hepatocellular carcinoma cells resist necrosis during anoxia by preventing phospholipase- mediated calpain activation. J Cell Physiol 167: 434-442, 1996. (Pubitemid 26168219)
19. Behrens MM, Martinez JL, Moratilla C and Renart J: Apoptosis induced by protein kinase C inhibition in a neuroblastoma cell line. Cell Growth Differ 6: 1375-1380, 1995.
20. Braun C, Engel M, Seifert M, Theisinger B, Seitz G, Zang KD and Welter C: Expression of calpain I messenger RNA in human renal cell carcinoma: correlation with lymph node metastasis and histological type. Int J Cancer 84: 6-9, 1999. (Pubitemid 29059100)
21. Ray SK, Patel SJ, Welsh CT, Wilford GG, Hogan EL and Banik NL: Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: up-regulation of calpain and caspase-3. J Neurosci Res 69: 197-206, 2002.
22. Reichrath J, Welter C, Mitschele T, Classen U, Meineke V, Tilgen W and Seifert M: Different expression patterns of calpain isozymes 1 and 2 (CAPN1 and 2) in squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) of human skin. J Pathol 199: 509-516, 2003. (Pubitemid 36411228)
23. Zhu W, Murtha PE and Young CY: Calpain inhibitor-induced apoptosis in human prostate adenocarcinoma cells. Biochem Biophys Res Commun 214: 1130-1137, 1995.
24. Deng JY, Chen SJ, Jow GM, Hsueh CW and Jeng CJ: Dehydroeburicoic acid induces calcium- and calpain- dependent necrosis in human U87MG glioblastomas. Chem Res Toxicol 22: 1817-26, 2009.
25. Huanjie Yang, Shalini Murthy, Fazlul H. Sarkar, Shije Sheng, G. Prem-Veer Reddy and Q Ping Dou: Calpain-mediated androgen receptor breakdown in apoptotic prostate cancer cells. J Cell Physiol 217: 569-576, 2008.
26. Lee SJ, Choi YL, Lee EJ, Kim BG, Bae DS, Ahn GH, Lee JH: Increased expression of calpain 6 in uterine sarcomas and carcinosarcomas: an immunohistochemical analysis. Int J Gyn Cancer 17: 248-253, 2006. (Pubitemid 46213998)
27. Kubbutat MH and Vousden KH: Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol Cell Biol 17: 460-468, 1997.
28. Benetti R, Del Sal G, Monte M, Paroni G, Brancolini C and Schneider C: The death substrate Gas2 binds m-calpain and increases subsceptibility to p53-dependent apoptosis. EMBO J 20: 2702-2714, 2001 (Pubitemid 32938555)
29. Glading A, Chang P, Lauffenburger DA and Wells A: Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem 275: 2390-2398, 2000. (Pubitemid 30081997)
30. Norberg E, Gogvadze V, VakifahmetoglunH, Orrenius S and Zhivotovsky B: Oxidative modification sensitizes mitochondrial apoptosis-inducing factor to calpain mediated processing. Free Radic Biol Med 28, 2009.